
Delays in cross-border carve-outs add hefty surcharge – report
An average 16% of deal value drains away when cross-border processes over-run for more than four months, according to a recent Mergermarket report commissioned by TMF Group.
An increase in the number of buyouts in which corporates sell a subsidiary has been noticeable in the past year; such transactions represented around 14% of all buyouts in 2019, up from 11.5% the year before and 10% in 2017, according to Unquote Data.
And although M&A volume is currently under severe pressure, the number of carve-out acquisitions is ultimately expected to rise as businesses look to restructure in the wake of the Covid-19 turmoil.
The difficulties in executing these transactions (and the associated rewards when GPs can successfully pull it off) are well documented, but the TMF report highlights how complications that arise in cross-border processes in particular can have a tangible impact on future investment performance.
The study surveyed 200 C-suite executives at private equity firms and corporate institutions based in 29 countries, all of whom had buy-side experience of a cross-border carve-out over the past three years.
Nearly a quarter (24%) of PE firms said their most recent deal took longer than expected, which can have a knock-on effect on costs – nearly all (92%) of those experiencing delays lasting more than four months said they cost them 10% or more of the original deal value, with the average surcharge standing at 16%.
According to Larry Harding, head of TMF in North America, firms are not factoring in the three keys to carve-out success: preparation, local presence and persistence. Failure in any one of these can cause delays, create unexpected costs and kill long-term deal value, he said.
Click here to download the full report
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater